Tag: Phico Therapeutics

Phico Therapeutics raises £7m to advance next-gen antibiotic candidate

by Lucy Parsons | May 11, 2021 | News | 0

Funds will support continued development of company’s SASPject platform and progression of lead product PT3.9

by Lucy Parsons | Apr 19, 2021 | News | 0

SASPject PT3.9 is designed for the treatment of hospital infections caused by Pseudomonas aeruginosa

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN